Company / Current Liabilities per Share
Catalyst Pharmaceuticals Partners, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.20
FY2025
5-year range
$0.26 / $1.20
FY2021-FY2025
Trend
+20.3%
vs FY2024
Sector context
#101 of 210
Health Care
What the data says
At $1.20, Catalyst Pharmaceuticals Partners, Inc.'s current liabilities per share ranks #110 of 210 in the Health Care sector. Current Liabilities per Share has increased for 5 consecutive years, from $0.22 in FY2020 to $1.20 in FY2025.
Based on SEC 10-K filings.
1.20 in FY2025 with a 5-year CAGR of +40.4%.
Increased from $0.71 to $1.20 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +30.0%
- 5-Year CAGR
- +40.4%
- 10-Year CAGR
- -
Sector benchmark
-94.9% below sector average
Key checks
Key Insights
- Catalyst Pharmaceuticals Partners, Inc.'s current liabilities per share has grown for 5 consecutive years.
- In FY2025, current liabilities per share increased 20.3% year-over-year.
- Ranks #101 out of 210 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.20 | +20.3% |
| FY2024 | $1.00 | +40.6% |
| FY2023 | $0.71 | +29.8% |
| FY2022 | $0.55 | +108.2% |
| FY2021 | $0.26 | +19.4% |
| FY2020 | $0.22 | -6.2% |
| FY2019 | $0.23 | +152.9% |
| FY2018 | $0.09 | +80.4% |
| FY2017 | $0.05 | +103.7% |
| FY2016 | $0.03 | -39.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026